Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
The FDA has just cleared a blood test to help make the diagnosis of Alzheimer’s disease, which otherwise may require some fairly invasive methods. Blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins, says the test looks for the …
Podcast: Download (Duration: 33:14 — 60.9MB)
Subscribe: RSS
Across large healthcare systems, the unexpected death of a colleague can be disruptively sad, but isn’t necessarily an uncommon event. Join a conversation between Jonathan Ripp and Lee Biddison on coordinating support for team members who have experienced the loss …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
NPTX2 is a protein that’s pivotal for helping your brain decide to remember certain things and forget others, and when levels of it decline it suggests that neurodegenerative processes like dementia may be beginning. That’s according to research by Paul …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Many theories on how brain disorders like Alzheimer’s disease begin point to proteins called amyloid beta and tau as accumulating and disrupting the function of neurons. Research by neuroscientist Paul Worley and colleagues at Johns Hopkins points to declining levels …
How do neurodegenerative diseases begin? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
NPTX2 is the abbreviation for a protein found in the brain that may allow much more accurate prognosis of who’s at risk for developing neurocognitive disorders, including Alzheimer’s disease and other dementias. That’s according to Johns Hopkins neuroscientist Paul Worley, …
